7 October 2013 - Newcastle: Aesica, the global contract development and manufacturing organisation (CDMO), has extended its aseptic capabilities at its Nottingham site with the acquisition of new ...
POMONA, Calif., Jan. 5, 2026 /PRNewswire/ -- Amsino International, Inc., a global manufacturer of single-use medical devices, announced the execution of an agreement with ampiezza. ampiezza, founded ...
WuXi Biologics, a CDMO, launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi ...
WUXI, China, June 5, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product ...
MedPro Safety Products has introduced a pre-filled safety syringe. The device contains a precise dose of pharmaceutical stored within a syringe system. The product also is equipped with a passive ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), announced today that the United States Food and Drug Administration (FDA) has approved a ...
POMONA, Calif., Feb. 3, 2026 /PRNewswire/ -- Amsino International, Inc. is pleased to announce a new three-year partnership with Partners Cooperative, effective January 1, 2026. This agreement ...
ZURICH--(BUSINESS WIRE)--Polpharma Biologics today announced Ranivisio® PFS (ranibizumab biosimilar pre-filled syringe), is now commercially available in France. Ranivisio® is the first Lucentis® ...
Please provide your email address to receive an email when new articles are posted on . The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema and retinal ...
IRVINE, Calif. Teva Health Systems has introduced its adenosine injection, USP in a pre-filled syringe, the company announced Wednesday. Teva’s adenosine is AP rated to Astellas Pharma’s Adenocard IV ...
The US Food and Drug Administration (FDA) has rejected a prefilled syringe version of Regeneron's ophthalmology blockbuster Eylea HD (aflibercept), as manufacturing shortcomings continue to plague the ...